Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples